AzTrials
AzTrials

Meniscal TearsBPTB,MeniscusNCT07088094

The Clinical Study of Bone-patellar Tendon-bone and Quasi-anatomical Meniscus Allograft Transplantation Technique

A study testing bone-patellar tendon-bone or meniscus allograft transplantation techniques and Quasi-anatomical meniscus allograft transplantation in people with Meniscal Tears and ACL - Anterior Cruciate Ligament Rupture, run by Beijing Tsinghua Chang Gung Hospital.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

This clinical study investigates the outcomes of bone-patellar tendon-bone and quasi-anatomical meniscus allograft transplantation techniques in patients requiring joint reconstruction. Read more about this study

Who is it for?
Ages 18 to 60 years
What is being tested?
bone-patellar tendon-bone or meniscus allograft transplantation techniques and Quasi-anatomical meniscus allograft transplantation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
No sites listed yet
Study dates
1 Aug 2025to 31 May 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Aged 18-50 years
  • Clinical diagnosis of symptomatic meniscal deficiency and anterior cruciate ligament injury (complete rupture or severe damage)
  • Failure of conservative treatment (e.g., physical therapy, analgesia) for ≥6 months
  • Stable knee joint (no ligamentous instability confirmed via clinical exam and MRI)
  • Willingness to comply with postoperative rehabilitation and follow-up evaluations

Who cannot join

  • Severe tibiofemoral osteoarthritis (Kellgren-Lawrence grade ≥3)
  • History of prior knee infection or septic arthritis
  • Inflammatory arthritis (e.g., rheumatoid arthritis, gout)
  • BMI ≥35 kg/m²
  • Pregnancy or planning pregnancy during the study period
  • Concurrent full-thickness chondral defects (Outerbridge grade III-IV) in the affected compartment
  • Inability to undergo MRI (e.g., claustrophobia, metallic implants)

About this study

This clinical study investigates the outcomes of bone-patellar tendon-bone and quasi-anatomical meniscus allograft transplantation techniques in patients requiring joint reconstruction. The study aims to assess the safety, efficacy, and functional improvements following these transplant procedures, utilizing donor tissues to restore joint function and alleviate pain in individuals with severe knee damage. Participants will undergo the transplantation procedure and be monitored for post-operative recovery, complications, and long-term outcomes, including joint stability and mobility. The study seeks to provide valuable insights into the effectiveness of these advanced surgical techniques for knee joint repair.

Being tested
bone-patellar tendon-bone or meniscus allograft transplantation techniques, Quasi-anatomical meniscus allograft transplantation
Medical subject headings
Anterior Cruciate Ligament Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • bone-patellar tendon-bone or meniscus allograft transplantation techniquesProcedure or surgery

    This clinical study follows an interventional design, focusing on the evaluation of bone-patellar tendon-bone and quasi-anatomical meniscus allograft transplantation techniques。

  • Quasi-anatomical meniscus allograft transplantationProcedure or surgery

    Quasi-anatomical meniscus allograft transplantation

Study groups in NCT07088094
Study groupRoleWhat they receive
Bone-patellar tendon-bone allograft transplantationExperimentalBone-patellar tendon-bone allograft transplantation
Receives: Procedure: bone-patellar tendon-bone or meniscus allograft transplantation techniques
Control groupNo interventionnon-surgical or conservative treatment group
Quasi-anatomical meniscus allograft transplantationExperimentalQuasi-anatomical meniscus allograft transplantation
Receives: Procedure: Quasi-anatomical meniscus allograft transplantation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of Postoperative Complications Unit of Measure

    Unit of Measure: Percentage of patients with complications (e.g., infection, graft failure, arthrofibrosis)

    Description: This measure evaluates the incidence of postoperative complications in patients undergoing bone-patellar tendon-bone and quasi-anatomical meniscus allograft transplantation techniques. The complications will be classified according to the Clavien-Dindo Classification for surgical complications, with clinical evaluations using physical examination and imaging to assess the occurrence of adverse events. The results will be reported as the percentage of patients experiencing any form of complication during the postoperative period.

    Measurement Tool: Clavien-Dindo Classification for surgical complications, clinical evaluation through physical examination, and imaging studies.

    Measured: 2 years

  2. Functional Improvement in Knee Joint Unit of Measure-Knee Society Score (KSS)

    Unit of Measure: Improvement in functional scores (0-100 scale)

    Description: This measure evaluates the improvement in knee function following bone-patellar tendon-bone and quasi-anatomical meniscus allograft transplantation techniques. Functional outcomes will be assessed using the Knee Society Score (KSS)

    What it measures:

    Knee Score (0-100): Knee-specific symptoms, alignment, stability. Function Score (0-100): Walking distance, stair-climbing, use of aids. Score Meaning: Higher = Better outcome. Note: Reported as two separate scores (not combined).

    Measurement Tool: Knee Society Score (KSS) and Lysholm Knee Score. The scale use a 0-100 range, where higher scores always indicate better knee function/health.

    Measured: 2 years

  3. Functional Improvement in Knee Joint Unit of Measure-Lysholm Knee Score

    Unit of Measure: Improvement in functional scores (0-100 scale)

    Description: This measure evaluates the improvement in knee function following bone-patellar tendon-bone and quasi-anatomical meniscus allograft transplantation techniques. Functional outcomes will be assessed using Lysholm Knee Score.

    Full Name: Lysholm Knee Scoring Scale Range: 0-100 What it measures: Stability, pain, daily function. Score Meaning: Higher = Better outcome.

    Measurement Tool: Lysholm Knee Score. The scale use a 0-100 range, where higher scores always indicate better knee function/health.

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jul 2025
  2. Study start1 Aug 2025 (estimated)
  3. Primary completion31 May 2028 (estimated)
  4. Study completion31 May 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07088094
Sponsor's protocol ID
25076-3-01
Other IDs
12110000318301495P
Acronym
BPTB,Meniscus
Status last verified
Jul 2025
First submitted
18 May 2025
Last updated
28 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Jiang D, Ao YF, Gong X, Wang YJ, Luo H, Chen LX, Wang HJ, Xie X, Zhang JY, Yu JK. Double-bundle anterior cruciate ligament reconstruction using bone-patellar tendon-bone allograft: technique and 2- to 5-year follow-up. Am J Sports Med. 2012 May;40(5):1084-92. doi: 10.1177/0363546512440686. Epub 2012 Apr 2.

    PubMed 22472270
  • Wang DY, Lee CA, Zhang B, Li YZ, Meng XY, Jiang D, Yu JK. The immediate meniscal allograft transplantation achieved better chondroprotection and less meniscus degeneration than the conventional delayed transplantation in the long-term. Knee Surg Sports Traumatol Arthrosc. 2022 Nov;30(11):3708-3717. doi: 10.1007/s00167-022-06982-9. Epub 2022 Apr 28.

    PubMed 35484433

Questions about this trial

What is this clinical trial studying?

A study testing bone-patellar tendon-bone or meniscus allograft transplantation techniques and Quasi-anatomical meniscus allograft transplantation in people with Meniscal Tears and ACL - Anterior Cruciate Ligament Rupture, run by Beijing Tsinghua Chang Gung Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 28 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of Postoperative Complications Unit of Measure (time frame: 2 years). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07088094, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in